<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:chebi fb="0" ids="36333">Local anesthetics</z:chebi> have been widely used for regional anesthesia and the treatment of <z:hpo ids='HP_0011675'>cardiac arrhythmias</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>Recent studies have also demonstrated that low dose systemic <z:chebi fb="39" ids="36333">local anesthetic</z:chebi> infusion has neuroprotective properties </plain></SENT>
<SENT sid="2" pm="."><plain>Considering the fact that excessive <z:chebi fb="6" ids="14321,29987">glutamate</z:chebi> release can cause neuronal excitotoxicity, we investigated whether <z:chebi fb="0" ids="36333">local anesthetics</z:chebi> might influence <z:chebi fb="6" ids="14321,29987">glutamate</z:chebi> release from rat cerebral cortex nerve terminals (synaptosomes) </plain></SENT>
<SENT sid="3" pm="."><plain>Results showed that two commonly used <z:chebi fb="0" ids="36333">local anesthetics</z:chebi>, <z:chebi fb="0" ids="6456">lidocaine</z:chebi> and <z:chebi fb="0" ids="3215">bupivacaine</z:chebi>, exhibited a dose-dependent inhibition of <z:chebi fb="1" ids="34385">4-AP</z:chebi>-evoked release of <z:chebi fb="6" ids="14321,29987">glutamate</z:chebi> </plain></SENT>
<SENT sid="4" pm="."><plain>The effects of <z:chebi fb="0" ids="6456">lidocaine</z:chebi> or <z:chebi fb="0" ids="3215">bupivacaine</z:chebi> on the evoked <z:chebi fb="6" ids="14321,29987">glutamate</z:chebi> release were prevented by the chelation of extracellular Ca(2) (+) ions and the vesicular transporter inhibitor <z:chebi fb="0" ids="22689">bafilomycin A1</z:chebi> </plain></SENT>
<SENT sid="5" pm="."><plain>However, the <z:chebi fb="6" ids="14321,29987">glutamate</z:chebi> transporter inhibitor DL-threo-beta-<z:chebi fb="0" ids="22744">benzyl</z:chebi>-oxyaspartate did not have any effect on the action of <z:chebi fb="0" ids="6456">lidocaine</z:chebi> or <z:chebi fb="0" ids="3215">bupivacaine</z:chebi> </plain></SENT>
<SENT sid="6" pm="."><plain>Both <z:chebi fb="0" ids="6456">lidocaine</z:chebi> and <z:chebi fb="0" ids="3215">bupivacaine</z:chebi> reduced the depolarization-induced increase in [Ca(2+) ]C , but did not alter <z:chebi fb="1" ids="34385">4-AP</z:chebi>-mediated depolarization </plain></SENT>
<SENT sid="7" pm="."><plain>Furthermore, the inhibitory effect of <z:chebi fb="0" ids="6456">lidocaine</z:chebi> or <z:chebi fb="0" ids="3215">bupivacaine</z:chebi> on evoked <z:chebi fb="6" ids="14321,29987">glutamate</z:chebi> release was prevented by blocking the Cav 2.2 (N-type) and Cav 2.1 (P/Q-type) channels, but was not affected by blockingof the <z:chebi fb="0" ids="8925">ryanodine</z:chebi> receptors or the <z:hpo ids='HP_0001427'>mitochondrial</z:hpo> <z:chebi fb="0" ids="29101">Na(+)</z:chebi> /Ca(2+) exchange </plain></SENT>
<SENT sid="8" pm="."><plain>Inhibition of protein kinase C (PKC) and protein kinase A (PKA) also prevented the action of <z:chebi fb="0" ids="6456">lidocaine</z:chebi> or <z:chebi fb="0" ids="3215">bupivacaine</z:chebi> </plain></SENT>
<SENT sid="9" pm="."><plain>These results show that <z:chebi fb="0" ids="36333">local anesthetics</z:chebi> inhibit <z:chebi fb="6" ids="14321,29987">glutamate</z:chebi> release from rat cortical nerve terminals </plain></SENT>
<SENT sid="10" pm="."><plain>This effect is linked to a decrease in [Ca(2+) ]C caused by Ca(2+) entry through presynaptic voltage-dependent Ca(2+) channels and the suppression of the PKA and PKC signaling cascades </plain></SENT>
<SENT sid="11" pm="."><plain>Synapse, 2013. Â© 2013 Wiley Periodicals, Inc </plain></SENT>
</text></document>